INVO Fertility Inc.
IVF | NASDAQ
$1
+$0.04 (+4.38%)
At close: Sep 22, 2026, 4:00 PM ET
$1
$0 (-0.16%)
After-hours:
Sep 22, 2026, 7:48 PM ET
Company Profile
INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.
Key Executives
| Name | Position |
|---|---|
| Steven Shum | Chief Executive Officer & Director |
| Terah Krigsvold | Chief Financial Officer |
| Andrea Goren | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 02, 2026 | 8-K | Current Report |
| Jun 02, 2026 | 10-K | Annual Report |
| Jun 02, 2026 | 8-K | Current Report |
| May 18, 2026 | NT 10-Q | Filing |
| May 15, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Apr 29, 2026 | 8-K | Current Report |
| Apr 01, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Apr 01, 2026 | NT 10-K | Filing |
| Mar 31, 2026 | 8-K | Current Report |
| Feb 24, 2026 | 8-K | Current Report |
INVO Fertility Inc.
| Country | United States |
| IPO Date | Nov 1, 2020 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 41 |
| CEO | Steven Shum |
Contact Details
5582 Broadcast Court Sarasota,
Florida 34240 United States
Stock Details
| Ticker Symbol | IVF |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001417926 |
| CUSIP Number | 44984F880 |
| ISIN Number | US44984F8804 |
| SIC Code | n/a |
Add to Watchlist
Select watchlists to add or remove IVF